Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,453,380
-
Share change
-
-626,483
-
Total reported value
-
$2,341,742,087
-
Put/Call ratio
-
194%
-
Price per share
-
$104.29
-
Number of holders
-
250
-
Value change
-
-$63,504,129
-
Number of buys
-
78
-
Number of sells
-
154
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2019
As of 31 Dec 2019,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,453,380 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, MACQUARIE GROUP LTD, Conestoga Capital Advisors, LLC, and Thrivent Financial for Lutherans.
This page lists
251
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.